Transcatheter aortic valve update 2013

被引：10
作者：
Bourantas, Christos V. [1 ]
Van Mieghem, Nicolas M. [1 ]
Soliman, Osama [2 ]
Campos, Carlos A. M. [1 ]
Iqbal, Javaid [1 ]
Serruys, Patrick W. [1 ]
机构：
[1] Erasmus MC, Thoraxctr, NL-3015 CE Rotterdam, Netherlands
[2] Cardialysis Imaging Core Lab, Rotterdam, Netherlands
来源：
EUROINTERVENTION | 2013年 / 9卷
关键词：
aortic stenosis; cardiovascular imaging; prognosis; transcatheter aortic valve implantation;
D O I：
10.4244/EIJV9SSA16
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cumulative evidence has demonstrated that transcatheter aortic valve implantation (TAVI) constitutes an effective treatment option for patients with severe symptomatic aortic stenosis and a high operative risk. New valve designs and TAVI-enabling devices have simplified the procedure, reduced the risk of complications, and broadened the applications of this treatment. The global adoption of TAVI allows us to appreciate the advantages, potentialities and caveats of the technology, identify patients who would benefit from TAVI and stratify more accurately the risk of complications. The focus of this article is to discuss the advances in this field, present the current evidence, and highlight the developments and strategies proposed to address the limitations of TAVI treatment.
引用
收藏
页码：S84 / S90
页数：7
相关论文
共 34 条
[1]  
Leon M.B., Smith C.R., Mack M., Miller D.C., Moses J.W., Svensson L.G., Tuzcu E.M., Webb J.G., Fontana G.P., Makkar R.R., Brown D.L., Block P.C., Guyton R.A., Pichard A.D., Bavaria J.E., Herrmann H.C., Douglas P.S., Petersen J.L., Akin J.J., Anderson W.N., Wang D., Pocock S., Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery, N Engl J Med., 363, pp. 1597-1607, (2010)
[2]  
Kodali S.K., Williams M.R., Smith C.R., Svensson L.G., Webb J.G., Makkar R.R., Fontana G.P., Dewey T.M., Thourani V.H., Pichard A.D., Fischbein M., Szeto W.Y., Lim S., Greason K.L., Teirstein P.S., Malaisrie S.C., Douglas P.S., Hahn R.T., Whisenant B., Zajarias A., Wang D., Akin J.J., Anderson W.N., Leon M.B., Two-year outcomes after transcatheter or surgical aortic-valve replacement, N Engl J Med., 366, pp. 1686-1695, (2012)
[3]  
Nielsen H.H., Klaaborg K.E., Nissen H., Terp K., Mortensen P.E., Kjeldsen B.J., Jakobsen C.J., Andersen H.R., Egeblad H., Krusell L.R., Thuesen L., Hjortdal V.E., A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. Surgical aortic valve replacement in operable elderly patients with aortic stenosis: The STACCATO trial, EuroIntervention., 8, pp. 383-389, (2012)
[4]  
Zahn R., Gerckens U., Linke A., Sievert H., Kahlert P., Hambrecht R., Sack S., Abdel-Wahab M., Hoffmann E., Schiele R., Schneider S., Senges J., Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis, Am J Cardiol., (2013)
[5]  
Gilard M., Eltchaninoff H., Iung B., Donzeau-Gouge P., Chevreul K., Fajadet J., Leprince P., Leguerrier A., Lievre M., Prat A., Teiger E., Lefevre T., Himbert D., Tchetche D., Carrie D., Albat B., Cribier A., Rioufol G., Sudre A., Blanchard D., Collet F., Dos Santos P., Meneveau N., Tirouvanziam A., Caussin C., Guyon P., Boschat J., Le Breton H., Collart F., Houel R., Delpine S., Souteyrand G., Favereau X., Ohlmann P., Doisy V., Grollier G., Gommeaux A., Claudel J.P., Bourlon F., Bertrand B., V
[6]  
Moat N.E., Ludman P., De Belder M.A., Bridgewater B., Cunningham A.D., Young C.P., Thomas M., Kovac J., Spyt T., MacCarthy P.A., Wendler O., Hildick-Smith D., Davies S.W., Trivedi U., Blackman D.J., Levy R.D., Brecker S.J., Baumbach A., Daniel T., Gray H., Mullen M.J., Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry, J Am Coll Cardiol., 58, pp. 2130
[7]  
Gurvitch R., Wood D.A., Tay E.L., Leipsic J., Ye J., Lichtenstein S.V., Thompson C.R., Carere R.G., Wijesinghe N., Nietlispach F., Boone R.H., Lauck S., Cheung A., Webb J.G., Transcatheter aortic valve implantation: Durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort, Circulation., 122, pp. 1319-1327, (2010)
[8]  
Ussia G.P., Barbanti M., Petronio A.S., Tarantini G., Ettori F., Colombo A., Violini R., Ramondo A., Santoro G., Klugmann S., Bedogni F., Maisano F., Marzocchi A., Poli A., De Carlo M., Napodano M., Fiorina C., De Marco F., Antoniucci D., De Cillis E., Capodanno D., Tamburino C., Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis, Eur Heart J., 33, pp. 969-976, (2012)
[9]  
Rodes-Cabau J., Webb J.G., Cheung A., Ye J., Dumont E., Osten M., Feindel C.M., Natarajan M.K., Velianou J.L., Martucci G., DeVarennes B., Chisholm R., Peterson M., Thompson C.R., Wood D., Toggweiler S., Gurvitch R., Lichtenstein S.V., Doyle D., DeLarochelliere R., Teoh K., Chu V., Bainey K., Lachapelle K., Cheema A., Latter D., Dumesnil J.G., Pibarot P., Horlick E., Long-term outcomes after transcatheter aortic valve implantation: Insights on prognostic factors and valve durability from the Ca
[10]  
Kappetein A.P., Head S.J., Genereux P., Piazza N., Van Mieghem N.M., Blackstone E.H., Brott T.G., Cohen D.J., Cutlip D.E., Van Es G.A., Hahn R.T., Kirtane A.J., Krucoff M.W., Kodali S., Mack M.J., Mehran R., Rodes-Cabau J., Vranckx P., Webb J.G., Windecker S., Serruys P.W., Leon M.B., Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document, EuroIntervention., 8, pp. 782-795, (2012)
1234